Literature DB >> 16040200

Impaired fatty acid oxidation as a cause of liver disease associated with hyperemesis gravidarum.

William M Outlaw1, Jamal A Ibdah.   

Abstract

Hyperemesis gravidarum (HG) is the most severe form of illness within the spectrum of nausea and vomiting of pregnancy. Liver disease, usually consisting of mild serum transaminase elevation, occurs in almost 50% of patients with HG. While multiple risk factors have been proposed, the etiology and underlying mechanism of maternal liver disease associated with HG remains unclear. In this report, we hypothesize that impairment of mitochondrial fatty acid oxidation (FAO) plays a role in the pathogenesis of maternal liver disease associated with HG. We hypothesize that women heterozygous for FAO defects develop HG associated with liver disease while carrying fetuses with FAO defects due to accumulation of fatty acids in placenta and subsequent generation of reactive oxygen species. Alternatively, it is possible that starvation leading to peripheral lipolysis and increased load of fatty acids in maternal-fetal circulation, combined with reduced capacity of the mitochondria to oxidize fatty acids in mothers heterozygous for FAO defects, can also cause HG and liver injury while carrying non-affected fetuses. The rationale for this hypothesis is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040200     DOI: 10.1016/j.mehy.2005.05.035

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  12 in total

1.  Recurrence risk of hyperemesis gravidarum.

Authors:  Marlena S Fejzo; Kimber W Macgibbon; Roberto Romero; T Murphy Goodwin; Patrick M Mullin
Journal:  J Midwifery Womens Health       Date:  2011-03-01       Impact factor: 2.388

2.  Familial aggregation of hyperemesis gravidarum.

Authors:  Yafeng Zhang; Rita M Cantor; Kimber MacGibbon; Roberto Romero; Thomas M Goodwin; Patrick M Mullin; Marlena S Fejzo
Journal:  Am J Obstet Gynecol       Date:  2010-10-25       Impact factor: 8.661

3.  Change in paternity and recurrence of hyperemesis gravidarum.

Authors:  Marlena S Fejzo; Chunyu Ching; Frederic P Schoenberg; Kimber Macgibbon; Roberto Romero; T Murphy Goodwin; Patrick M Mullin
Journal:  J Matern Fetal Neonatal Med       Date:  2011-11-24

Review 4.  Pregnancy-related liver disorders.

Authors:  Ashish Goel; Kapil D Jamwal; Anup Ramachandran; Kunissery A Balasubramanian; Chundamannil E Eapen
Journal:  J Clin Exp Hepatol       Date:  2013-03-16

Review 5.  Liver diseases in pregnancy: diseases unique to pregnancy.

Authors:  Khulood T Ahmed; Ashraf A Almashhrawi; Rubayat N Rahman; Ghassan M Hammoud; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

6.  High prevalence of severe nausea and vomiting of pregnancy and hyperemesis gravidarum among relatives of affected individuals.

Authors:  Marlena S Fejzo; Sue Ann Ingles; Melissa Wilson; Wei Wang; Kimber MacGibbon; Roberto Romero; Thomas M Goodwin
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2008-08-26       Impact factor: 2.435

Review 7.  Advances in understanding and treating liver diseases during pregnancy: A review.

Authors:  Kenya Kamimura; Hiroyuki Abe; Hirokazu Kawai; Hiroteru Kamimura; Yuji Kobayashi; Minoru Nomoto; Yutaka Aoyagi; Shuji Terai
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

Review 8.  Pregnancy-associated liver disorders.

Authors:  Iryna S Hepburn; Robert R Schade
Journal:  Dig Dis Sci       Date:  2008-02-07       Impact factor: 3.199

9.  Differences in Liver Injury and Trophoblastic Mitochondrial Damage in Different Preeclampsia-like Mouse Models.

Authors:  Yi-Wei Han; Zi Yang; Xiao-Yan Ding; Huan Yu
Journal:  Chin Med J (Engl)       Date:  2015-06-20       Impact factor: 2.628

Review 10.  Role of 3-Hydroxy Fatty Acid-Induced Hepatic Lipotoxicity in Acute Fatty Liver of Pregnancy.

Authors:  Sathish Kumar Natarajan; Jamal A Ibdah
Journal:  Int J Mol Sci       Date:  2018-01-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.